BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 19237097)

  • 21. The prognostic impact of uric acid in patients with severely decompensated acute heart failure.
    Okazaki H; Shirakabe A; Kobayashi N; Hata N; Shinada T; Matsushita M; Yamamoto Y; Shibuya J; Shiomura R; Nishigoori S; Asai K; Shimizu W
    J Cardiol; 2016 Nov; 68(5):384-391. PubMed ID: 27261247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of low serum levels of apolipoprotein A-I with adverse outcomes in patients with nonischemic heart failure.
    Iwaoka M; Obata JE; Abe M; Nakamura T; Kitta Y; Kodama Y; Kawabata K; Takano H; Fujioka D; Saito Y; Kobayashi T; Hasebe H; Kugiyama K
    J Card Fail; 2007 May; 13(4):247-53. PubMed ID: 17517342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center].
    Zoghi M; Duygu H; Güngör H; Nalbantgil S; Yilmaz GM; Tülüce K; Ozerkan F; Akilli A; Akin M
    Anadolu Kardiyol Derg; 2008 Aug; 8(4):255-9. PubMed ID: 18676300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
    Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
    Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of the relative lymphocyte count to predict one-year mortality in patients with acute heart failure.
    Núñez J; Núñez E; Miñana G; Sanchis J; Bodí V; Rumiz E; Palau P; Olivares M; Merlos P; Bonanad C; Mainar L; Llàcer A
    Am J Cardiol; 2011 Apr; 107(7):1034-9. PubMed ID: 21296316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.
    Chen JH; Chuang SY; Chen HJ; Yeh WT; Pan WH
    Arthritis Rheum; 2009 Feb; 61(2):225-32. PubMed ID: 19177541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
    Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS).
    Holme I; Aastveit AH; Hammar N; Jungner I; Walldius G
    J Intern Med; 2009 Dec; 266(6):558-70. PubMed ID: 19563390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants and Prognostic Impact of Hyperuricemia in Hospitalization for Acute Heart Failure.
    Huang WM; Hsu PF; Cheng HM; Lu DY; Cheng YL; Guo CY; Sung SH; Yu WC; Chen CH
    Circ J; 2016; 80(2):404-10. PubMed ID: 26597355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between serum uric acid level and heart failure and mortality in the early period of ST-elevation acute myocardial infarction.
    Gazi E; Temiz A; Altun B; Barutçu A; Bekler A; Güngör O; Yener AU; Kurt T; Ozcan S; Gazi S
    Turk Kardiyol Dern Ars; 2014 Sep; 42(6):501-8. PubMed ID: 25362938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is uric acid a predictive factor for graft dysfunction in renal transplant recipients?
    Akgul A; Bilgic A; Ibis A; Ozdemir FN; Arat Z; Haberal M
    Transplant Proc; 2007 May; 39(4):1023-6. PubMed ID: 17524881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Significance of Hyperuricemia in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; Beltrami M; Giordano N; Nuti R; McCullough PA
    Am J Cardiol; 2016 May; 117(10):1616-1621. PubMed ID: 27040576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study.
    Filippatos G; Rossi J; Lloyd-Jones DM; Stough WG; Ouyang J; Shin DD; O'connor C; Adams KF; Orlandi C; Gheorghiade M
    J Card Fail; 2007 Jun; 13(5):360-4. PubMed ID: 17602982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study).
    Kojima S; Sakamoto T; Ishihara M; Kimura K; Miyazaki S; Yamagishi M; Tei C; Hiraoka H; Sonoda M; Tsuchihashi K; Shimoyama N; Honda T; Ogata Y; Matsui K; Ogawa H;
    Am J Cardiol; 2005 Aug; 96(4):489-95. PubMed ID: 16098298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between serum uric acid and perioperative and late cardiovascular outcome in patients with suspected or definite coronary artery disease undergoing elective vascular surgery.
    Dunkelgrun M; Welten GM; Goei D; Winkel TA; Schouten O; van Domburg RT; van Gestel YR; Flu WJ; Hoeks SE; Bax JJ; Poldermans D
    Am J Cardiol; 2008 Oct; 102(7):797-801. PubMed ID: 18805100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure.
    Michowitz Y; Kisil S; Guzner-Gur H; Rubinstein A; Wexler D; Sheps D; Keren G; George J
    Isr Med Assoc J; 2008 Dec; 10(12):884-8. PubMed ID: 19160948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum aldosterone is associated with mortality and re-hospitalization in patients with reduced ejection fraction hospitalized for acute heart failure: analysis from the EVEREST trial.
    Girerd N; Pang PS; Swedberg K; Fought A; Kwasny MJ; Subacius H; Konstam MA; Maggioni A; Gheorghiade M; Zannad F;
    Eur J Heart Fail; 2013 Nov; 15(11):1228-35. PubMed ID: 23787720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.